Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”, together with its subsidiaries, the “Company”), a space ...

The president of the United States urged lawmakers to do everything they can to make the long-desired Alaska natural gas pipeline a reality. “It is in the national interest to bring Alaskan gas ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. The Dow ...

A Claude Code plugin that orchestrates 7 specialized AI agents to take your feature request all the way from requirements analysis to production deployment — with a human-in-the-loop checkpoint at ...

Whitehawk Therapeutics (WHWK) announced on Wednesday that it has entered into a securities purchase agreement for an $87.5M private investment in public equity, or PIPE, financing, before deducting ...

Microsoft Research is excited to release an open dataset of approximate transmission topology of the U.S. power grid derived from publicly available data. The ability to study transmission-level power ...

The project involves adding almost 140 kilometres of new pipe by constructing 11 looping segments parallel to the existing line. While the gas that would flow through the expanded line is not bound ...

CALGARY — The federal government has approved a $4-billion plan by Enbridge Inc. to expand an existing natural gas pipeline in British Columbia, a move one executive says demonstrates a greater "sense ...

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary ...

High-performance computing (HPC) plays a critical role in scientific discovery, engineering simulation, and data-intensive applications. Open Multi-Processing (OpenMP) is one of the most widely ...

Radiopharmaceutical pipelines are broadening beyond prostate cancer into multitumor programs, pairing alpha/beta emitters with immunotherapy or DDR agents and driving investments in isotope supply, ...